World Journal of Clinical Cases - Baishideng Publishing Group

Advanced Search

BPG is committed to discovery and dissemination of knowledge

JOURNAL HOME

Number of total visits: 4428037

Number of visits today: 4035

Number of downloads: 4063591

MEMBERSHIP

BPG JOURNALS

Cited by in F6Publishing

For:	Pellanda AF, De Bari B, Deniaud-Alexandre E, Krengli M, Van Houtte P, Richetti A, Villà S, Goldberg H, Szutowicz-Zielińska E, Bolla M, Rutten H, Van Eijkeren M, Poortmans P, Henke G, Anacak Y, Chan S, Landmann C, Kirkove C, Scandolaro L, Bernier J, Mirimanoff RO, Ozsahin M. Outcome and prognostic factors in 110 consecutive patients with primary uterine leiomyosarcoma: A Rare Cancer Network study. Chin J Cancer Res 2017;29:521-32. [PMID: 29353974 DOI: 10.21147/j.issn.1000-9604.2017.06.06] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]

For:

Pellanda AF, De Bari B, Deniaud-Alexandre E, Krengli M, Van Houtte P, Richetti A, Villà S, Goldberg H, Szutowicz-Zielińska E, Bolla M, Rutten H, Van Eijkeren M, Poortmans P, Henke G, Anacak Y, Chan S, Landmann C, Kirkove C, Scandolaro L, Bernier J, Mirimanoff RO, Ozsahin M. Outcome and prognostic factors in 110 consecutive patients with primary uterine leiomyosarcoma: A Rare Cancer Network study. Chin J Cancer Res 2017;29:521-32. [PMID: 29353974 DOI: 10.21147/j.issn.1000-9604.2017.06.06] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]

Number	Citing Articles
1	姜倩. Risk Factors for Metastasis with Uterine Leiomyosarcoma. ACM 2022;12:284-290. [DOI: 10.12677/acm.2022.121043] [Reference Citation Analysis]
2	Tse KY, Wong RW, Chao A, Ueng SH, Yang LY, Cummings M, Smith D, Lai CR, Lau HY, Yen MS, Cheung AN, Leung CK, Chan KS, Chan AN, Li WH, Choi CK, Pong WM, Hui HF, Yuk JY, Yao H, Yuen NW, Obermair A, Lai CH, Ip PP, Ngan HY. Development of a Multi-Institutional Prediction Model for Three-Year Survival Status in Patients with Uterine Leiomyosarcoma (AGOG11-022/QCGC1302 Study). Cancers (Basel) 2021;13:2378. [PMID: 34069227 DOI: 10.3390/cancers13102378] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
3	Kyriazoglou A, Liontos M, Ntanasis-Stathopoulos I, Gavriatopoulou M. The systemic treatment of uterine leiomyosarcomas: A systematic review. No news is good news? Medicine (Baltimore) 2021;100:e25309. [PMID: 33787622 DOI: 10.1097/MD.0000000000025309] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
4	Parra-herran C. Mesenchymal and Miscellaneous Lesions of the Uterus. Gynecologic Pathology 2020. [DOI: 10.1016/b978-0-323-35909-2.00011-4] [Reference Citation Analysis]
5	Howitt BE, Nucci MR. Uterine Mesenchymal Lesions. Gynecologic and Obstetric Pathology, Volume 2 2019. [DOI: 10.1007/978-981-13-3019-3_1] [Reference Citation Analysis]